Drug class
Ophthalmic Sympatholytic Agents
Ophthalmic sympatholytic agents are a pharmacologic group of topical ocular medications, predominantly beta-adrenergic receptor antagonists such as timolol and betaxolol, that inhibit sympathetic adrenergic activity within ocular tissues. Read more about Ophthalmic Sympatholytic Agents
41 drugs in this class 23 manufacturers
Drugs in Ophthalmic Sympatholytic Agents
BRIMONIDINE TARTRATE-TIMOLOL (brimonidine tartrate/timolol maleate)
BRIMONIDINE TARTRATE
BRIMONIDINE TARTRATE
BRIMONIDINE TARTRATE
Ophthalmic sympatholytic agents are a pharmacologic group of topical ocular medications, predominantly beta-adrenergic receptor antagonists such as timolol and betaxolol, that inhibit sympathetic adrenergic activity within ocular tissues.
These agents lower intraocular pressure primarily by suppressing cyclic AMP-mediated secretion of aqueous humor by the ciliary body epithelium.
As a therapeutic class, they are indicated for managing elevated intraocular pressure in conditions such as open-angle glaucoma and ocular hypertension to prevent optic neuropathy and visual loss.
-
nih.gov
Ophthalmic sympatholytic agents are a pharmacologic group of topical ocular medications, predominantly beta-adrenergic receptor antagonists such as timolol and betaxolol, that inhibit sympathetic adrenergic activity within ocular tissues
-
slideshare.net
Ophthalmic sympatholytic agents are a pharmacologic group of topical ocular medications, predominantly beta-adrenergic receptor antagonists such as timolol and betaxolol, that inhibit sympathetic adrenergic activity within ocular tissues These agents lower intraocular pressure primarily by suppressing cyclic AMP-mediated secretion of aqueous humor by the ciliary body epithelium As a therapeutic class, they are indicated for managing elevated intraocular pressure in conditions such as open-angle ...
-
nih.gov
Ophthalmic sympatholytic agents are a pharmacologic group of topical ocular medications, predominantly beta-adrenergic receptor antagonists such as timolol and betaxolol, that inhibit sympathetic adrenergic activity within ocular tissues
-
nih.gov
These agents lower intraocular pressure primarily by suppressing cyclic AMP-mediated secretion of aqueous humor by the ciliary body epithelium As a therapeutic class, they are indicated for managing elevated intraocular pressure in conditions such as open-angle glaucoma and ocular hypertension to prevent optic neuropathy and visual loss
-
nih.gov
As a therapeutic class, they are indicated for managing elevated intraocular pressure in conditions such as open-angle glaucoma and ocular hypertension to prevent optic neuropathy and visual loss
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.